Current trends in monoclonal antibody development and manufacturing:
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
Springer [u.a.]
2010
|
Schriftenreihe: | Biotechnology
pharmaceutical aspects ; 11 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | XIV, 351 S. Ill., graph. Darst. |
ISBN: | 9780387766423 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV036037753 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 100217s2010 ad|| |||| 00||| eng d | ||
015 | |a 07N440926 |2 dnb | ||
016 | 7 | |a 985943866 |2 DE-101 | |
020 | |a 9780387766423 |c Gb |9 978-0-387-76642-3 | ||
035 | |a (OCoLC)496951432 | ||
035 | |a (DE-599)DNB985943866 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
050 | 0 | |a QR186.85 | |
082 | 0 | |a 571.96 | |
084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
084 | |a 610 |2 sdnb | ||
245 | 1 | 0 | |a Current trends in monoclonal antibody development and manufacturing |c ed. by Steven J. Shire... |
264 | 1 | |a New York [u.a.] |b Springer [u.a.] |c 2010 | |
300 | |a XIV, 351 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Biotechnology : pharmaceutical aspects |v 11 | |
650 | 4 | |a Antibodies, Monoclonal |x analysis | |
650 | 4 | |a Antibodies, Monoclonal |x biosynthesis | |
650 | 4 | |a Antibodies, Monoclonal |x pharmacokinetics | |
650 | 4 | |a Biotechnology |x methods | |
650 | 4 | |a Monoclonal antibodies | |
700 | 1 | |a Shire, Steven J. |4 edt | |
830 | 0 | |a Biotechnology |v pharmaceutical aspects ; 11 |w (DE-604)BV021640956 |9 11 | |
856 | 4 | |m DE-601 |q pdf/application |u http://www.gbv.de/dms/bs/toc/54749386X.pdf |z kostenfrei |3 Inhaltsverzeichnis | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018929697&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-018929697 |
Datensatz im Suchindex
_version_ | 1804141064727035904 |
---|---|
adam_text | Titel: Current trends in monoclonal antibody development and manufacturing
Autor: Shire, Steven J.
Jahr: 2010
Contents
1 Introduction........................................................................................ 1
Wayne R. Gombotz and Steven J. Shire
Part I Design Of Therapeutic MABS
2 CDR Repair: A Novel Approach to Antibody Humanization........... 9
Mark S. Dennis
3 Nanobodies, Single-Domain Antigen-Binding Fragments
of Camelid Heavy-Chain Antibodies................................................. 29
Gholamreza Hassanzadeh Ghassabeh, Serge Muyldermans, and
Dirk Saerens
Part II Expression and Production of MABS
4 GPEx® A Flexible Method for the Rapid Generation of Stable,
High Expressing, Antibody Producing Mammalian Cell Lines........ 51
Gregory T. Bleck
5 Advancing Our Cell Culture Platform: Incorporating
Lessons Learned and New Technologies........................................... 63
Carole Heath
Part III Recovery and Purification
6. Addressing Changes Associated with Technology Transfer:
A Case Study...................................................................................... 75
Michele M. Myers, Camille Keating, Joann Bannon,
Donald S. Neblock, and Peter W. Wojciechowski
7 Concepts for Disposables in Biopharmaceutical Manufacture.......... 87
Joachim K. Walter and Uwe Gottschalk
Part IV Formulation and Delivery
8 Formulation and Delivery Issues for Monoclonal
Antibody Therapeutics....................................................................... 103
Ann L. Dougherty and Randall J. Mrsny
x Contents
9 Challenges in the Development of High Protein
Concentration Formulations............................................................... 131
Steven J. Shire, Zahra Shahrokh, and Jun Liu
10 Protein Immobilization by Crystallization and Precipitation:
An Alternative to Lyophilization....................................................... 149
Karoline Bechtold-Peters
Part V Analytics and Specification Setting for MABS
11 Characterizing High Affinity Antigen/Antibody Complexes
by Kinetic and Equilibrium Based Methods...................................... 179
Andrew W. Drake, David G. Myszka, and Scott L. Klakamp
12 Analytical Characterization of Monoclonal Antibodies:
Linking Structure to Function............................................................ 193
Reed J. Harris, Edward T. Chin, Frank Macchi, Rodney G.
Keck, Bao-Jen Shyong, Victor T. Ling, Armando J. Cordoba,
Melinda Marian, Don Sinclair, John E. Battersby, and
Andy J.S. Jones
13 Analysis of Irreversible Aggregation, Reversible
Self-association and Fragmentation of Monoclonal
Antibodies by Analytical Ultracentrifugation.................................... 207
James D. Andya, Jun Liu, and Steven J. Shire
14 Biophysical Signatures of Monoclonal Antibodies........................... 229
N. Harn, T. Spitznagel, M. Perkins, C. Allan, S. Shire,
and C. R. Middaugh
Part VI Pharmacokinetics and Immunogenicity
15 Impact of Fc Glycosylation on Monoclonal Antibody
Effector Functions and Degradation by Proteases............................... 249
T. Shantha Raju
16 Immunogenicity Assessment of Antibody Therapeutics................... 271
R Stas, Y. Gansemans, and I. Lasters
Part VII Armed Antibodies and New Classes of Antibodies
17 Production of Monoclonal Antibodies in E. coli............................... 295
Dorothea E. Reilly and Daniel G. Yansura
18 Recent Advancements in the Use of Antibody Drug
Conjugates for Cancer Therapy......................................................... 309
Peter D. Senter
19 Antibody Radiolabeling..................................................................... 323
Corinne Bensimon and Russell Redshaw
Index.......................................................................................................... 345
|
any_adam_object | 1 |
author2 | Shire, Steven J. |
author2_role | edt |
author2_variant | s j s sj sjs |
author_facet | Shire, Steven J. |
building | Verbundindex |
bvnumber | BV036037753 |
callnumber-first | Q - Science |
callnumber-label | QR186 |
callnumber-raw | QR186.85 |
callnumber-search | QR186.85 |
callnumber-sort | QR 3186.85 |
callnumber-subject | QR - Microbiology |
classification_rvk | VS 9400 |
ctrlnum | (OCoLC)496951432 (DE-599)DNB985943866 |
dewey-full | 571.96 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 571 - Physiology & related subjects |
dewey-raw | 571.96 |
dewey-search | 571.96 |
dewey-sort | 3571.96 |
dewey-tens | 570 - Biology |
discipline | Chemie / Pharmazie Biologie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01691nam a2200433 cb4500</leader><controlfield tag="001">BV036037753</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100217s2010 ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">07N440926</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">985943866</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780387766423</subfield><subfield code="c">Gb</subfield><subfield code="9">978-0-387-76642-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)496951432</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB985943866</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR186.85</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">571.96</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current trends in monoclonal antibody development and manufacturing</subfield><subfield code="c">ed. by Steven J. Shire...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Springer [u.a.]</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 351 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Biotechnology : pharmaceutical aspects</subfield><subfield code="v">11</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">biosynthesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">pharmacokinetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shire, Steven J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Biotechnology</subfield><subfield code="v">pharmaceutical aspects ; 11</subfield><subfield code="w">(DE-604)BV021640956</subfield><subfield code="9">11</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="m">DE-601</subfield><subfield code="q">pdf/application</subfield><subfield code="u">http://www.gbv.de/dms/bs/toc/54749386X.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018929697&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018929697</subfield></datafield></record></collection> |
id | DE-604.BV036037753 |
illustrated | Illustrated |
indexdate | 2024-07-09T22:09:56Z |
institution | BVB |
isbn | 9780387766423 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018929697 |
oclc_num | 496951432 |
open_access_boolean | 1 |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | XIV, 351 S. Ill., graph. Darst. |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Springer [u.a.] |
record_format | marc |
series | Biotechnology |
series2 | Biotechnology : pharmaceutical aspects |
spelling | Current trends in monoclonal antibody development and manufacturing ed. by Steven J. Shire... New York [u.a.] Springer [u.a.] 2010 XIV, 351 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Biotechnology : pharmaceutical aspects 11 Antibodies, Monoclonal analysis Antibodies, Monoclonal biosynthesis Antibodies, Monoclonal pharmacokinetics Biotechnology methods Monoclonal antibodies Shire, Steven J. edt Biotechnology pharmaceutical aspects ; 11 (DE-604)BV021640956 11 DE-601 pdf/application http://www.gbv.de/dms/bs/toc/54749386X.pdf kostenfrei Inhaltsverzeichnis HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018929697&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Current trends in monoclonal antibody development and manufacturing Biotechnology Antibodies, Monoclonal analysis Antibodies, Monoclonal biosynthesis Antibodies, Monoclonal pharmacokinetics Biotechnology methods Monoclonal antibodies |
title | Current trends in monoclonal antibody development and manufacturing |
title_auth | Current trends in monoclonal antibody development and manufacturing |
title_exact_search | Current trends in monoclonal antibody development and manufacturing |
title_full | Current trends in monoclonal antibody development and manufacturing ed. by Steven J. Shire... |
title_fullStr | Current trends in monoclonal antibody development and manufacturing ed. by Steven J. Shire... |
title_full_unstemmed | Current trends in monoclonal antibody development and manufacturing ed. by Steven J. Shire... |
title_short | Current trends in monoclonal antibody development and manufacturing |
title_sort | current trends in monoclonal antibody development and manufacturing |
topic | Antibodies, Monoclonal analysis Antibodies, Monoclonal biosynthesis Antibodies, Monoclonal pharmacokinetics Biotechnology methods Monoclonal antibodies |
topic_facet | Antibodies, Monoclonal analysis Antibodies, Monoclonal biosynthesis Antibodies, Monoclonal pharmacokinetics Biotechnology methods Monoclonal antibodies |
url | http://www.gbv.de/dms/bs/toc/54749386X.pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018929697&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV021640956 |
work_keys_str_mv | AT shirestevenj currenttrendsinmonoclonalantibodydevelopmentandmanufacturing |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis